In the screening of pregnant individuals for GDM, careful selection of the most practical and reliable diagnostic test is crucial, as the underlying pathophysiology of GDM is primarily characterized by impaired insulin secretion or reduced insulin sensitivity [4]; therefore, surrogate markers of insulin resistance may serve as effective predictors for its development. Here, INS is linked to Insulin resistance.